Accessibility: Skip TopNav
Palisade Bio, Inc.
Phase 2 ASCENTRA-CD clinical trial in patients with moderate to severe Crohn’s disease (CD)
Format
PNG
Quelle:
Palisade Bio, Inc.
Downloads
Originalgröße
Groß
Mittel
Klein